Logo
  • Investing
  • Stock
  • Economy
  • Latest News
Skip to content
Stock
  • Economy
  • Investing
  • Latest News
  • Stock
#
Categories Stock

Nebius stock: to buy or not to buy this AI infrastructure play?

October 1, 2025

The ongoing surge in the Nebius stock price has led to divisions in Wall Street. Many investors believe that it has more

#
Categories Stock

Tilray stock price forecast as it faces major headwinds

October 1, 2025

Tilray stock price has surged in the past few weeks, with most of the gains happening on Monday when it surged by

#
Categories Stock

Avoid JEPQ and buy the 14% yielding QQQI ETF instead

September 30, 2025

Covered call ETFs have become highly popular among income investors in the past few years because of their high distribution rate. The

#
Categories Stock

Rivian stock price analysis: is the recovery at risk?

September 30, 2025

Rivian stock price has rebounded in the past few weeks, moving from the August low of $11.53 to $16 today. It is

#
Categories Stock

Top catalysts for the Nasdaq 100 Index and ETFs like QQQ, JEPQ

September 30, 2025

The Nasdaq 100 Index has rallied this year, helped by the ongoing tailwinds in the artificial intelligence industry. It ended the week

#
Categories Stock

Nike stock price hits a key support before earnings: buy or sell?

September 30, 2025

The Nike stock price has retreated in the past few weeks and moved to the strong, pivot, reverse level at $68.75 as

#
Categories Stock

Top catalysts for the Nikkei 225 Index in Q4’25

September 30, 2025

The Nikkei 225 Index, which tracks the biggest companies in Japan, retreated to the important support level at ¥45,000, down from the

#
Categories Stock

ASX 200 Index wavers after the RBA leaves interest rates decision

September 30, 2025

The ASX 200 Index held steady on Tuesday after the latest Reserve Bank of Australia (RBA) interest rate decision on Tuesday morning.

#
Categories Stock

Barclays share price to benefit as Q3 M&A deals top $1 trillion

September 30, 2025

Barclays share price has jumped in the past few months and is hovering at its highest point since 2007. It has soared

#
Categories Stock

USD/ZAR forecast: Here’s why the South African rand is rallying

September 30, 2025

The South African rand is having a great performance this year even as the country’s economy face substantial risks. The USD/ZAR exchange

Posts navigation

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

    Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!



    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Trending News

    • Recent Posts
    #

    S&P 500, Dow Jones, Nasdaq 100 crash explained: will they rebound?

    The S&P 500, Dow Jones, and Nasdaq 100 indices and their exchange-traded funds (ETF) future...

    #

    Crypto market price predictions: Zcash, Shiba Inu, Morpho

    The crypto market crawled back today, October 18, as traders bought the recent dip and as hopes of...

    #

    Top crypto market news to watch this week

    The crypto market was highly volatile last week as investors reacted to the recent liquidation that...

    #

    Slotland Celebrates 27 Years of iGaming Innovation with New Games and Birthday Promotions

    The post Slotland Celebrates 27 Years of iGaming Innovation with New Games and Birthday Promotions...

    #

    Best Crypto To Buy Now: Why MUTM Stands Out Over XRP

    The post Best Crypto To Buy Now: Why MUTM Stands Out Over XRP appeared first on Coinpedia Fintech...

    #

    3 High-Potential Altcoins that Could Retire You This Year – Find Out Experts’ Top Picks

    The post 3 High-Potential Altcoins that Could Retire You This Year – Find Out Experts’ Top...

    • About us
    • Contacts
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: Biotech-savvy.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 Biotech-savvy.com